Distlerath named APCO SVP

WASHINGTON: Dr. Linda M. Distlerath, previously VP of global health policy and health policy in the Asia Pacific for Merck & Co., has been named SVP at APCO Worldwide. Distlerath specializes in HIV/AIDS vaccine policy issues, and collaboration with NGOs, foundations, and other organizations.

27 November 2007

WASHINGTON: Dr. Linda M. Distlerath, previously VP of global health policy and health policy in the Asia Pacific for Merck & Co., has been named SVP at APCO Worldwide. Distlerath specializes in HIV/AIDS vaccine policy issues, and collaboration with NGOs, foundations, and other organizations.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Up next:

The NFL expands its metaverse presence in Fortnite Creative

The NFL expands its metaverse presence in Fortnite Creative

Walker Zimmerman started for the US against England. (Photo credit: Getty Images).

HHS calls on U.S. men’s soccer squad to give COVID boosters a leg up

VoxComm issued a statement about the red alert on Tuesday. (Photo credit: Getty Images).

Keurig Dr Pepper stands by payment terms after backlash from trade bodies

Discord rolls out monetization tiers for creators

Discord rolls out monetization tiers for creators

Thomson Reuters refreshes comms team with new global and UK leads

Thomson Reuters refreshes comms team with new global and UK leads

Breakfast Briefing: 5 things for PR pros to know on Friday morning

Breakfast Briefing: 5 things for PR pros to know on Friday morning

DKC is based in New York.

DKC appoints Tracy Royal as co-head of DKCulture

(Photo credit: Getty Images).

Twitter halts COVID-19 misinformation policy in latest business pivot

L-R: Rebecca Grant, Melanie Mitchem and Catherine Sullivan. (Photo credits, respectively: Alex Rumford, Peter Hurley and Harrison Steg)

BCW names Rebecca Grant global chief brand officer

Few legislative wins, many investigations: How companies should prepare for the new Congress

Few legislative wins, many investigations: How companies should prepare for the new Congress